- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT04072536
Evaluation on Standardized Circuits of the Interest of a Robotic Module of Assistance to the Driving 1 (SWADAPT1)
Оценка по стандартизированным схемам интереса роботизированного модуля помощи при вождении пациентов с неврологическими расстройствами, обычных водителей электрических инвалидных колясок.
The device that is the subject of this investigation is a robotic assistance module for driving a semi-autonomous electric wheelchair. This module is designed to accessorize the electric wheelchair to improve the safety conditions when driving an electric wheelchair, thus reducing the wheelchair accident rate on the one hand and facilitating access to the wheelchair to persons who can not claim it without the use of a safety device of this type.
Обзор исследования
Статус
Условия
Подробное описание
The device that is the subject of this investigation is a robotic assistance module for driving a semi-autonomous electric wheelchair. This module is designed to accessorize the electric wheelchair to improve the safety conditions when driving an electric wheelchair, thus reducing the wheelchair accident rate on the one hand and facilitating access to the wheelchair to persons who can not claim it without the use of a safety device of this type.
Each patient included will test a wheelchair equipped with a collision avoidance assistance module in 2 conditions, assistance activated or not. This evaluation will be carried out in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient will perform the circuit 6 times, including 3 with activated assistance, in a random order established upstream.
Тип исследования
Регистрация (Действительный)
Фаза
- Непригодный
Контакты и местонахождение
Места учебы
-
-
Brittany Region
-
Rennes, Brittany Region, Франция, 35000
- Pôle Saint-Hélier
-
-
Критерии участия
Критерии приемлемости
Возраст, подходящий для обучения
Принимает здоровых добровольцев
Полы, имеющие право на обучение
Описание
Inclusion Criteria:
- Aged over 18,
- Having freely consented to participate in the study,
- suffering from neurological disorders such as cerebro-lesion or neuro-degeneration,
- Having benefited from a prescription of electric wheelchair and circulating in an electric wheelchair for more than 3 months,
- of which the electric wheelchair is the main mode of transport,
- The physical measurements (weight, height) are compatible with the use of the electric wheelchair chosen for the development of the robotics assistance module.
Exclusion Criteria:
- Understanding difficulties preventing the realization of the protocol,
- Motor disorders of the upper limb requiring additional driving technical assistance,
- Patient having expressed difficulties impacting his safety of sedan and / or exterior.
Учебный план
Как устроено исследование?
Детали дизайна
- Основная цель: Другой
- Распределение: Рандомизированный
- Интервенционная модель: Назначение кроссовера
- Маскировка: Двойной
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: Electric wheelchair with activated assistance module
This condition will be achieved in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient will perform the circuit 6 times, including 3 with activated assistance, in a random order established upstream. |
This evaluation will be carried out in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient will perform the circuit 6 times, including 3 with activated assistance |
|
Другой: Electric wheelchair with assistance module not activated
This condition will be achieved in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient will perform the circuit 6 times, including 3 without activated assistance, in a random order established upstream. |
This evaluation will be carried out in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient will perform the circuit 6 times, including 3 with no activated assistance |
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Number of collision
Временное ограничение: Day 1
|
The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module. |
Day 1
|
|
Number of collision
Временное ограничение: Day 8
|
The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module. |
Day 8
|
|
Number of collision
Временное ограничение: Day 15
|
The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module. |
Day 15
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Driving Speed
Временное ограничение: Day 1, Day 8 and Day 15
|
Speed measured by the completion time of the course with and without activation of the assistance system on the different circuits |
Day 1, Day 8 and Day 15
|
|
Wheelchair Skill Test
Временное ограничение: Day 1, Day 8 and Day 15
|
Driving performance measured by the Wheelchair Skill Test items corresponding to the different courses, with and without activation of the assistance system |
Day 1, Day 8 and Day 15
|
|
NASA-Task Load Index
Временное ограничение: Day 1, Day 8 and Day 15
|
The cognitive load of tests under both conditions will be measured by the NASA-Task Load Index. It is in the form of six scales where the participant must assign a score between zero and one hundred to each of them, score indicating a growing level of intensity. Three dimensions relate to the demands imposed on the subject (mental, physical and temporal demands) and three to the interaction of a subject with the task (effort, frustration and performance) |
Day 1, Day 8 and Day 15
|
|
Ease of Use Questionnaire
Временное ограничение: Day 1, Day 8 and Day 15
|
The satisfaction of the use of the electric wheelchair under the conditions will be evaluated by the self-questionnaire Ease of Use Questionnaire. It measures the subjective usability of a product or service. It is a 30-item survey that examines four dimensions of usability: usefulness, ease of use, ease of learning, and satisfaction. The questionnaires were constructed as seven-point Likert rating scales. Users were asked to rate agreement with the statements, ranging from strongly disagree (1) to strongly agree (7). |
Day 1, Day 8 and Day 15
|
|
UTAUT (Unified theory of acceptance of technology) questionnaire
Временное ограничение: Day 1, Day 8 and Day 15
|
Questionnaire of acceptability / acceptance of the tool and its use by patients based on the Unified Theory of Acceptance and Use Technology (UTAUT). |
Day 1, Day 8 and Day 15
|
Соавторы и исследователи
Спонсор
Следователи
- Главный следователь: Philippe Gallien, Doctor, Pôle Saint Hélier
Даты записи исследования
Изучение основных дат
Начало исследования (Действительный)
Первичное завершение (Действительный)
Завершение исследования (Действительный)
Даты регистрации исследования
Первый отправленный
Впервые представлено, что соответствует критериям контроля качества
Первый опубликованный (Действительный)
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
Последнее отправленное обновление, отвечающее критериям контроля качества
Последняя проверка
Дополнительная информация
Термины, связанные с этим исследованием
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- 2019-A00476-51
Планирование данных отдельных участников (IPD)
Планируете делиться данными об отдельных участниках (IPD)?
Информация о лекарствах и устройствах, исследовательские документы
Изучает лекарственный продукт, регулируемый FDA США.
Изучает продукт устройства, регулируемый Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов США.
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .